万孚生物：第五届董事会第二十一次会议决议公告

Group 1 - The core point of the article is that Wanfu Biological announced the approval of a proposal to lower the conversion price of its convertible bonds [2] Group 2 - The announcement was made during the 21st meeting of the fifth board of directors [2]